Corrigendum: Late-stage MC38 tumours recapitulate features of human colorectal cancer – implications for appropriate timepoint selection in preclinical studies

• Nicholas J. Shields,
• Nicholas J. Shields,
• Estelle M. Peyroux,
• Angela L. Ferguson,
• Angela L. Ferguson,
• Angela L. Ferguson,
• Megan Steain,
• Silke Neumann,
• Sarah L. Young,
• Sarah L. Young

Affiliations

Nicholas J. Shields

School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia

Nicholas J. Shields

Department of Pathology, Otago Medical School, University of Otago, Dunedin, New Zealand

Estelle M. Peyroux

Department of Pathology, Otago Medical School, University of Otago, Dunedin, New Zealand

Angela L. Ferguson

School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia

Angela L. Ferguson

Liver Injury and Cancer Program, Centenary Institute, Sydney, NSW, Australia

Angela L. Ferguson

Charles Perkins Centre, University of Sydney, Sydney, NSW, Australia

Megan Steain

School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia

Silke Neumann

Department of Pathology, Otago Medical School, University of Otago, Dunedin, New Zealand

Sarah L. Young

School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia

Sarah L. Young

Faculty of Science, University of Canterbury, Christchurch, New Zealand